Arcalyst OverviewRilonacept, also known as IL-1 Trap (marketed by Regeneron Pharmaceuticals under the trade name Arcalyst), is an interleukin 1 inhibitor. Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component (IL-1R1) and IL-1 receptor accessory protein (IL-1RAcP) linked in-line to the fragment-crystallizable portion (Fc region) of human IgG1 that binds and neutralizes IL-1.[2...
Read more Arcalyst Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rilonacept
Recent Arcalyst Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Vial: 220mg
NDC Database Records for Arcalyst: (1 result)Sorted by National Drug Code
- 61755-001 Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Regeneron Pharmaceuticals, Inc.